e2v Announces Turnkey Contract for Cancer Radiotherapy Equipment
SEOUL, SOUTH KOREA -- (Marketwire) -- 01/30/13 -- e2v, the
innovative solutions provider, has announced that it has signed a new
multi-year contract with Accuray Incorporated, based in Sunnyvale,
California for the supply of compact modulators and magnetrons for
their TomoTherapy(R) Hi-Art(R) System, used for the treatment of
The contract covers a 5 year period for the exclusive supply of
magnetrons and a 3 year period for the supply of compact modulators,
both from e2v's RF Power division based in Chelmsford UK. The
contract is worth a minimum of GBP 20m.
e2v's compact modulators and magnetrons represent critical technology
within the TomoTherapy Hi-Art System, providing the microwave power
which is converted into X-rays for the imaging and radiation
treatment of tumours.
The products supplied will be used in new systems and for the ongoing
support of the worldwide installed base.
Chris Pick, VP of sales at e2v commented 'We are delighted to be
working with Accuray in support of their life enhancing medical
systems. This contract is a great example of our partnership approach
to forging long term relationships with global industry leaders."
e2v is a leading global provider of specialist technology for high
performance systems and equipment; delivering solutions, sub-systems
and components for specialist applications within medical & science,
aerospace & defence, and commercial & industrial markets.
e2v has its headquarters in the UK, employs approximately 1650
people, has design and production facilities across Europe and North
America, and has a global network of sales and technical support
offices. For the year ended 31 March 2012, e2v reported sales of
GBP235m and is listed on the London Stock Exchange.
For more information visit e2v.com
PRESS OFFICE CONTACT:
Press spacebar to pause and continue. Press esc to stop.